Novalung System receives US FDA Clearance
The US FDA (Food and Drug Administration) has granted 510(k) approval to Fresenius Medical Care North America and Xenios…
The US FDA (Food and Drug Administration) has granted 510(k) approval to Fresenius Medical Care North America and Xenios…
Novalung GmbH, which specialises in solutions for respiratory failure, was absorbed into Xenios AG on 30 August 2019. Pr…
The Xenios AG, pioneer in extracorporeal heart and lung support, has restructured its website. Xenios AG has been part o…
Originally launched as Novalung Academy, present-day Xenios Academy is celebrating its tenth anniversary. With training…
The dramatic story of Canadian Melissa Benoit, who lived for six days without a lung, shows a view of a new chapter in t…
XENIOS AG, the technology and therapy leader in lung and heart assist becomes part of Fresenius Medical Care & Co. KGaA,…
XENIOS AG, the leader in lung and heart assist therapies, unites the novalung, i-cor, and medos websites into www.xenios…
XENIOS AG, a commercial -stage medical device company, announced today that it has received a significant cash infusion…
The iLA activve® further extends its leadership as the only lung assist platform with a complete range of four different…
The iLA activve® further extends its leadership as the only lung assist platform with a complete range of four different…